| |
Original Artikel |
Datum |
Titel |
Autoren Alle Autoren |
| 1 |
[GO] |
2026―Mrz―21 |
Proteome-wide autoantibody screening and holistic autoantigenomic analysis unveil COVID-19 signature of autoantibody landscape |
Kazuki M. Matsuda, Yoshiaki Kawase, Kazuhiro Iwadoh, Makoto Kurano, Yutaka Yatomi, Koh Okamoto, et al. (+24) Kyoji Moriya, Hirohito Kotani, Teruyoshi Hisamoto, Ai Kuzumi, Takemichi Fukasawa, Asako Yoshizaki-Ogawa, Masanori Kono, Tomohisa Okamura, Hirofumi Shoda, Keishi Fujio, Kei Yamaguchi, Taishi Okumura, Chihiro Ono, Yuki Kobayashi, Ayaka Sato, Ayako Miya, Rikako Uchino, Yumi Murakami, Hiroshi Matsunaka, Hiroshi Imai, Shinichi Sato, Rudy Raymond, Ayumi Yoshizaki, Naoki Goshima |
| 2 |
[GO] |
2026―Jan―31 |
Polypore mushroom mycelia as an adjunct to COVID-19 vaccination: a randomized clinical trial |
Gordon Saxe, Christine N. Smith, Shahrokh Golshan, Tatyana Shekhtman, Zolton J. Bair, Chase Beathard, et al. (+7) Renee A. Davis, Lauray MacElhern, Andrew Shubov, Daniel Slater, Lan K. Kao, Phoebe Senowitz, Stephen Wilson |
| 3 |
[GO] |
2025―Nov―14 |
Inflammatory tropism in COVID-19: a comparative analysis of Delta and Omicron variants |
Afshin Samiei, Ali Jandaghi, Mehdi Hassani Azad, Mahmood Khayatian, Narges Khaghanzadeh |
| 4 |
[GO] |
2025―Mai―19 |
Evaluation of the effect of the COVID-19 pandemic on depression, anxiety and psychological resilience in patients with primary immunodeficiency |
Anıl Muştucu, Rümeysa Ayşe Güllülü, Sukru Cekic, Sara Sebnem Kilic, Selçuk Kırlı |
| 5 |
[GO] |
2025―Apr―16 |
Incidence of severe adverse events in cancer patients after treatment with immune-checkpoint inhibitors during the COVID- 19 pandemic |
Sakiko Kimura, Hiroo Katsuya, Chiho Nakashima, Naoko Sueoka-Aragane, Koji Hayashida, Kazumi Sasaki, et al. (+15) Rintaro Sogawa, Tatsuya Furuno, Moriyasu Yamauchi, Yoichiro Sugiyama, Hirokazu Noshiro, Motohiro Esaki, Mitsuru Noguchi, Hirokazu Takahashi, Keizo Anzai, Masatoshi Yokoyama, Kazunari Sugita, Yoshio Yamashita, Atsushi Kawaguchi, Shinya Kimura, Chisato Shimanoe |
| 6 |
[GO] |
2025―Mrz―15 |
Monitoring of immunoglobulin treatment compliance of patients with an inborn error of immunity during the pandemic period |
Yasin Karali, Zuhal Karali, Sukru Cekic, Irem Cakir, Sara Sebnem Kilic |
| 7 |
[GO] |
2024―Okt―26 |
Chemokine CCL2 and its receptor CCR2 in different age groups of patients with COVID-19 |
Vahid Bagheri, Hossein Khorramdelazad, Mehdi Kafi, Mitra Abbasifard |
| 8 |
[GO] |
2024―Jul―26 |
Multiplex array analysis of circulating cytokines and chemokines in COVID-19 patients during the first wave of the SARS-CoV-2 pandemic in Milan, Italy |
Estefanía Calvo-Alvarez, Sarah D’Alessandro, Nunzia Zanotta, Nicoletta Basilico, Silvia Parapini, Lucia Signorini, et al. (+8) Federica Perego, Kevin Kamau Maina, Pasquale Ferrante, Annalisa Modenese, Pierluigi Pizzocri, Andrea Ronsivalle, Serena Delbue, Manola Comar |
| 9 |
[GO] |
2024―Jun―28 |
The effects of killer cell immunoglobulin-like receptor (KIR) genes on susceptibility to severe COVID-19 in the Iranian population |
Narges Karami, Shaghik Barani, Mona Fani, Seppo Meri, Reza Shafiei, Kurosh Kalantar |
| 10 |
[GO] |
2024―Jun―19 |
Humoral immune response and safety of Sars-Cov-2 vaccine in people with multiple sclerosis |
Seyedeh Sadigheh Hamzavi, Rosemina Bahrololoom, Sepideh Saeb, Nahid Heydari Marandi, Marzieh Hosseini, Alimohammad Keshtvarz hesam abadi, Marzieh Jamalidoust |
| 11 |
[GO] |
2024―Jan―13 |
IgG antibody response to SARS-CoV-2 infection and its influencing factors in lymphoma patients |
Huan Xie, Jing Zhang, Ran Luo, Yan Qi, Yizhang Lin, Changhao Han, et al. (+2) Xi Li, Dongfeng Zeng |
| 12 |
[GO] |
2023―Nov―16 |
Long-term humoral and cellular immunity after primary SARS-CoV-2 infection: a 20-month longitudinal study |
Astrid Korning Hvidt, Huaijian Guo, Rebecca Andersen, Stine Sofie Frank Lende, Line Khalidan Vibholm, Ole Schmeltz Søgaard, et al. (+6) Marianne Hoegsbjerg Schleimann, Victoria Russell, Angela Man-Wei Cheung, Eustache Paramithiotis, Rikke Olesen, Martin Tolstrup |
| 13 |
[GO] |
2023―Sep―26 |
The development of a highly sensitive and quantitative SARS-CoV-2 rapid antigen test applying newly developed monoclonal antibodies to an automated chemiluminescent flow-through membrane immunoassay device |
Kengo Nishimura, Hiroaki Kitazawa, Takashi Kawahata, Kosuke Yuhara, Takahiro Masuya, Toshihiro Kuroita, et al. (+4) Kentarou Waki, Seiichi Koike, Masaharu Isobe, Nobuyuki Kurosawa |
| 14 |
[GO] |
2023―Sep―18 |
Evaluation of the relationship between serum interleukin-1β levels and expression of inflammasome-related genes in patients with COVID-19 |
Zahra Bagheri-Hosseinabadi, Ali Shamsizadeh, Fatemeh Bahrehmand, Mitra Abbasifard |
| 15 |
[GO] |
2022―Nov―16 |
A longitudinal study of humoral immune responses induced by a 3-dose inactivated COVID-19 vaccine in an observational, prospective cohort |
Yue Tao, Mengyin Ma, Fenghua Hu, Ming Li, Yu Geng, Yawen Wan, et al. (+6) Minxin Mao, Lin Chen, Ya Shen, Liguo Zhu, Han Shen, Yuxin Chen |
| 16 |
[GO] |
2022―Okt―26 |
Restoration of dendritic cell homeostasis and Type I/Type III interferon levels in convalescent COVID-19 individuals |
Anuradha Rajamanickam, Nathella Pavan Kumar, Arul Nancy Pandiaraj, Nandhini Selvaraj, Saravanan Munisankar, Rachel Mariam Renji, et al. (+10) Vijayalakshmi Venkatramani, Manoj Murhekar, Jeromie Wesley Vivian Thangaraj, Muthusamy Santhosh Kumar, Chethrapilly Purushothaman Girish Kumar, Tarun Bhatnagar, Manickam Ponnaiah, Ramasamy Sabarinathan, Velusamy Saravanakumar, Subash Babu |
| 17 |
[GO] |
2022―Feb―16 |
Antibody attributes that predict the neutralization and effector function of polyclonal responses to SARS-CoV-2 |
Harini Natarajan, Shiwei Xu, Andrew R. Crowley, Savannah E. Butler, Joshua A. Weiner, Evan M. Bloch, et al. (+15) Kirsten Littlefield, Sarah E. Benner, Ruchee Shrestha, Olivia Ajayi, Wendy Wieland-Alter, David Sullivan, Shmuel Shoham, Thomas C. Quinn, Arturo Casadevall, Andrew Pekosz, Andrew D. Redd, Aaron A. R. Tobian, Ruth I. Connor, Peter F. Wright, Margaret E. Ackerman |
| 18 |
[GO] |
2021―Okt―19 |
Humoral and cellular response to SARS-CoV-2 BNT162b2 mRNA vaccine in hemodialysis patients |
Jan Melin, Maria K. Svensson, Bo Albinsson, Ola Winqvist, Karlis Pauksens |
| 19 |
[GO] |
2021―Mrz―25 |
Vaccinomic approach for novel multi epitopes vaccine against severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) |
Yassir A. Almofti, Khoubieb Ali Abd-elrahman, Elsideeq E. M. Eltilib |
| 20 |
[GO] |
2021―Feb―20 |
The seroprevalence and kinetics of IgM and IgG in the progression of COVID-19 |
Xuzhen Qin, Jun Shen, Erhei Dai, Haolong Li, Guodong Tang, Lixia Zhang, et al. (+8) Xin Hou, Minya Lu, Xian Wu, Simeng Duan, Jingjia Zhang, Man-Fung Tsoi, Ping Jiang, Yongzhe Li |
|